Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs
about
Identification of novel functional inhibitors of acid sphingomyelinaseRestoration of immune response by a cationic amphiphilic drug (AY 9944) in vitro: a new approach To chemotherapy against human immunodeficiency virus type 1Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytesRetinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic featuresCationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.WASH is required for lysosomal recycling and efficient autophagic and phagocytic digestion.Roles and regulation of secretory and lysosomal acid sphingomyelinase.Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.Cell surface ceramide generation precedes and controls FcgammaRII clustering and phosphorylation in rafts.Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.Uptake and degradation of several pyrenesphingomyelins by skin fibroblasts from control subjects and patients with Niemann-Pick disease. Effect of the structure of the fluorescent fatty acyl residue.Endosomal Acidification and Activation of NADPH Oxidase Isoforms Are Upstream Events in Hyperosmolarity-induced Hepatocyte Apoptosis
P2860
Q21003953-6D8311B0-CD24-45EA-AFEF-2D1B86D3CABBQ28369001-35B248E1-1E42-4E4A-A1C4-728AAD5CB384Q28578424-31626D8D-F610-4A24-89BD-9F038EDA7D90Q33834588-67CF6099-9B43-43C4-9325-FB8F13FD661FQ35947304-6C50EA6D-7410-44FE-81DB-BA41C8AB95E6Q37131503-E2F14FCB-E9B2-4945-8299-F0F302977373Q37454661-DFF45FE3-DEAB-4FE9-84D1-6E77FDA721E1Q37880161-3C589CCD-7547-4073-9031-F680B8AE63B0Q40546049-56C64227-D7BF-4C08-BBFB-B0D23F9CF02EQ41435445-BBD2698B-345D-4F30-B2AD-2F3F0219635FQ42859951-305108CE-377D-4D36-AE72-5CF0DCE43A87Q57372482-2DE65D35-B1E1-42B6-997E-87B291EE6D2F
P2860
Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs
description
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1985
@ast
im Dezember 1985 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: December 1985)
@en
vedecký článok (publikovaný 1985-12)
@sk
vědecký článek publikovaný v roce 1985
@cs
wetenschappelijk artikel (gepubliceerd in 1985-12)
@nl
наукова стаття, опублікована в грудні 1985
@uk
مقالة علمية (نشرت في ديسمبر 1985)
@ar
name
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@ast
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@en
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@nl
type
label
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@ast
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@en
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@nl
prefLabel
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@ast
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@en
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@nl
P2093
P1476
Reduction of acid sphingomyeli ...... her cationic amphiphilic drugs
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.JBCHEM.A135438
P407
P577
1985-12-01T00:00:00Z